Fact Check

Fact Check: Is 'Livfavir' Cheaper Than Glenmark's 'Fabiflu'?

Aditi Chattopadhyay

Glenmark Pharmaceuticals on June 20 had announced the launch of its antiviral drug Favipiravir, under the brand name 'Fabiflu', to treat mild to moderate COVID-19 cases in India. As per reports, based on clinical evidence and after the evaluation of data and in consultation with the Subject Expert...